Genworth Financial Inc (GNW) Stock Price & How to Invest

Genworth Financial, based in Richmond, Virginia, is what is left of a much larger insurer after two decades of restructuring. It reports three main pieces. Enact is a private mortgage insurance business that Genworth took public in 2021 and still owns roughly 81% of, and it produces essentially all of the group's operating earnings. The Long-Term Care Insurance segment is a closed block: policies written largely between the 1970s and the 2000s, no longer sold, whose claims and reserves Genworth manages down over decades. A smaller Life and Annuities segment is also in runoff. The newer effort is CareScout, which builds a quality-assured network of home care and senior living providers, earns fees on placements and preferred pricing, and through CareScout Insurance is writing fresh long-term care coverage on modern assumptions. Trailing twelve-month revenue is ~$7.4 billion against a market capitalisation of ~$3.84 billion at ~$10.16 per share.

The investment picture is dominated by one arithmetic gap. Enact carries a market value of ~$6.9 billion, so Genworth's ~81% is worth ~$5.5 billion, roughly 1.4x Genworth's whole market cap. The market is therefore assigning a negative value to everything else: the long-term care block, holding company debt, corporate expense, and CareScout's spending. Cash keeps moving up from Enact regardless, and Genworth expects ~$445 million to ~$485 million from it in 2026 out of ~$550 million to ~$600 million of total Enact capital returns, which funds share repurchases and debt reduction at the holding company. Q2 2026 adjusted operating income excluding the closed block was ~$112 million, or ~$0.29 per diluted share, while the closed block continued to record losses. Whether the discount narrows depends on the long-term care block behaving, and on whether repurchases at these prices are enough to force the issue.

The core risk is that the long-term care closed block turns out to cost more than reserved: morbidity, mortality, policyholder lapse behaviour and long-run interest rates all feed the reserve, and a deterioration can require capital that the holding company would rather deploy elsewhere. Rate increases are approved one state at a time, so the multi-year rate action plan can slow without warning. Because Enact supplies almost all earnings and cash, a US housing downturn would hit Genworth twice, through mortgage delinquencies and through the market value of the stake itself. There is no announced plan to divest or distribute Enact, so the holding company discount can persist for years regardless of what the parts are worth. Genworth also remains a defendant in policyholder class actions over long-term care rate increase disclosures, and while the long-running securities class action was dismissed on summary judgment in August 2026, litigation outcomes are outside the company's control.

We give no verdict on Genworth Financial Inc. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Enact cash flow and the holding company discount. Enact is a well-capitalised mortgage insurer with a seasoned insurance-in-force book, and its dividends and buyback participation are Genworth's primary source of cash.

The case against. The core risk is that the long-term care closed block turns out to cost more than reserved: morbidity, mortality, policyholder lapse behaviour and long-run interest rates all feed the reserve, and a deterioration can require capital that the holding company would rather deploy elsewhere.

Read the full bull and bear case on GNW, including what would have to change to break either one. Walnut is not an investment adviser.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Genworth Financial Inc's investor relations page or your broker.

• Revenue (TTM): ~$7.4 billion
• Market cap: ~$3.84 billion (~$10.16 per share)
• Enact stake: ~81% of Enact Holdings (ACT), worth ~$5.5 billion at Enact's ~$6.9 billion market value
• Adjusted operating income ex-closed block (Q2 2026): ~$112 million, or ~$0.29 per diluted share
• Holding company cash and liquid assets: ~$215 million at June 30, 2026
• 2026 share repurchase outlook: ~$225 million to ~$250 million (~$62 million repurchased in Q2 2026)

Figures are approximate and tied to the asOf date; check live numbers before acting. Standard earnings multiples do little work here, because GAAP results consolidate all of Enact while charging the full drag of the long-term care closed block, and reported equity of ~$8.7 billion at June 30, 2026 includes the minority interest in Enact and swings with accumulated other comprehensive income. Most analysis of GNW is sum-of-the-parts instead: the market value of the Enact stake, less holding company debt and corporate costs, less whatever haircut the long-term care block deserves.

Other names that sit close to GNW: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get GNW exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so GNW sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where GNW fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

GNW is a sum-of-the-parts situation: a listed mortgage insurance stake currently worth more than Genworth's entire market capitalisation, less a legacy long-term care block whose ultimate cost nobody can pin down.

Whether GNW is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is GNW a buy or a sell?, and where the stock could go from here in the GNW stock forecast.

For income investors, whether GNW pays a dividend and how the payout looks is covered in does GNW pay a dividend? And to weigh GNW against a peer, read the full side-by-side comparisons: GNW vs MTG and GNW vs ESNT.